Flu Vaccine Market Report
RA00761
Flu Vaccine Market, by Type (Trivalent, Quadrivalent), End Use (Hospitals & Clinics, Research Laboratories, Academic Institutes, Others), Virus Type (Inactivated Virus, Live Attenuated Virus, Recombinant Virus, Others), Age (Below 18 years, 18 – 65 years, Above 65 years), Route Of Administration (Intramuscular, Intradermal, Nasal, Others): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global flu vaccine market is estimated to surpass $6,521.8 million by 2027, exhibiting a CAGR of 5.7% from 2020 to 2027.
The report provides all-inclusive analysis of global flu vaccine market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.
The report emphasizes current market scenario and future trends of the global flu vaccine market which gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market. Besides, the report provides Porter’s five forces analysis which precisely underlines the impact of key forces on the global flu vaccine market.
In addition, the report provides market size and forecast scrutinizing global flu vaccine market through different segments. The report highlights the geographical market analysis of these segments and each segment is thoroughly studied at regional as well as country level to get clearer picture of the global flu vaccine market. In the report, the global flu vaccine market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover flu vaccine market landscape in respective regions.
Furthermore, competitive scenario of the global flu vaccine market is covered in the report. Major players functioning in the global flu vaccine market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global flu vaccine market, and others.
Research Methodology
Research Dive offers its clients extensive research and analysis gleaned from wide variety of factual inputs that largely includes interview with participants of the industry, reliable data & statistics, and regional intelligence. The in-house experts of the industry play a crucial role in designing analytic tools and models, tailor-made to the requests of an industry segment. The data and statistics are sterilized with these analytical tools and models, which enhances the accuracy of our advice and recommendations.
This research report is delivered by Research Dive by conducting long hours of discussions and interviews, with a broad range of stakeholders, which includes upstream and downstream participants. Our analysts have performed a mix of primary and secondary research for the market estimations and forecasts. A number of product type literatures, industry releases, annual reports, and other related documents of major participants of the industry have been reviewed, to better understand the global flu vaccine market scenario. The initial phase of our in-depth study, where we perform wide-range data mining, referring to proficient & verified data sources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and other.
KEY MARKET BENEFITS
- This report is a compilation of detailed study, information, valid inputs from industry experts & industry participants across the value chain, and quantitative & qualitative assessment by analysts of the industry.
- The report provides a comprehensive analysis along with the current trends of market during the forecast period from 2019 to 2027 to identify & comprehend the prevailing opportunities and the strategic assessment of the global flu vaccine market growth.
- The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies.
- The report provides market estimations and size which is based on in-depth analysis of recent & key developments in the flu vaccine market.
- The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global flu vaccine market.
KEY MARKET SEGMENTS
The market has been studied based on the following segments:
- Type: Trivalent, Quadrivalent
- End Use: Hospitals & Clinics, Research Laboratories, Academic Institutes, Others
- Virus Type: Inactivated Virus, Live Attenuated Virus, Recombinant Virus, Others
- Age: Below 18 years, 18
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Flu Vaccine Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Flu Vaccine Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Flu Vaccine Market, By Product
5.1. Overview
5.2 Trivalent
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Quadrivalent
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Research Dive Exclusive Insights
5.4.1 Market attractiveness
5.4.2 Competition heatmap
-
6. Flu Vaccine Market, By Application
6.1. Overview
6.2 Hospitals & Clinics
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Research Laboratories
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Academic Institutes
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Others
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Research Dive Exclusive Insights
6.6.1 Market attractiveness
6.6.2 Competition heatmap
-
7. Flu Vaccine Market, By Therapeutic Area
7.1. Overview
7.2 Inactivated Virus
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Live Attenuated Virus
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Recombinant Virus
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Others
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Research Dive Exclusive Insights
7.6.1 Market attractiveness
7.6.2 Competition heatmap
-
8. Flu Vaccine Market, By Testing Type
8.1. Overview
8.2 Below 18 years
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 18 – 65 years
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Above 65 years
8.4.1 Definition, key trends, growth factors, and opportunities
8.4.2 Market size analysis, by region, 2020-2027
8.4.3 Market share analysis, by country, 2020-2027
8.5 Research Dive Exclusive Insights
8.5.1 Market attractiveness
8.5.2 Competition heatmap
-
9. Flu Vaccine Market, By Treatment
9.1. Overview
9.2 Intramuscular
9.2.1 Definition, key trends, growth factors, and opportunities
9.2.2 Market size analysis, by region, 2020-2027
9.2.3 Market share analysis, by country, 2020-2027
9.3 Intradermal
9.3.1 Definition, key trends, growth factors, and opportunities
9.3.2 Market size analysis, by region, 2020-2027
9.3.3 Market share analysis, by country, 2020-2027
9.4 Nasal
9.4.1 Definition, key trends, growth factors, and opportunities
9.4.2 Market size analysis, by region, 2020-2027
9.4.3 Market share analysis, by country, 2020-2027
9.5 Others
9.5.1 Definition, key trends, growth factors, and opportunities
9.5.2 Market size analysis, by region, 2020-2027
9.5.3 Market share analysis, by country, 2020-2027
9.6 Research Dive Exclusive Insights
9.6.1 Market attractiveness
9.6.2 Competition heatmap
10. Flu Vaccine Market, By Region
10.1 North America
10.1.1 U.S
10.1.1.1 Market size analysis, By Product, 2020-2027
10.1.1.2 Market size analysis, By Application, 2020-2027
10.1.1.3 Market size analysis, By Therapeutic Area, 2020-2027
10.1.1.4 Market size analysis, By Testing Type, 2020-2027
10.1.1.5 Market size analysis, By Treatment, 2020-2027
10.1.2 Canada
10.1.2.1 Market size analysis, By Product, 2020-2027
10.1.2.2 Market size analysis, By Application, 2020-2027
10.1.2.3 Market size analysis, By Therapeutic Area, 2020-2027
10.1.2.4 Market size analysis, By Testing Type, 2020-2027
10.1.2.5 Market size analysis, By Treatment, 2020-2027
10.1.3 Mexico
10.1.3.1 Market size analysis, By Product, 2020-2027
10.1.3.2 Market size analysis, By Application, 2020-2027
10.1.3.3 Market size analysis, By Therapeutic Area, 2020-2027
10.1.3.4 Market size analysis, By Testing Type, 2020-2027
10.1.3.5 Market size analysis, By Treatment, 2020-2027
10.1.4 Research Dive Exclusive Insights
10.1.4.1 Market attractiveness
10.1.4.2 Competition heatmap
10.2 Europe
10.2.1 Germany
10.2.1.1 Market size analysis, By Product, 2020-2027
10.2.1.2 Market size analysis, By Application, 2020-2027
10.2.1.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.1.4 Market size analysis, By Testing Type, 2020-2027
10.2.1.5 Market size analysis, By Treatment, 2020-2027
10.2.2 UK
10.2.2.1 Market size analysis, By Product, 2020-2027
10.2.2.2 Market size analysis, By Application, 2020-2027
10.2.2.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.2.4 Market size analysis, By Testing Type, 2020-2027
10.2.2.5 Market size analysis, By Treatment, 2020-2027
10.2.3 France
10.2.3.1 Market size analysis, By Product, 2020-2027
10.2.3.2 Market size analysis, By Application, 2020-2027
10.2.3.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.3.4 Market size analysis, By Testing Type, 2020-2027
10.2.3.5 Market size analysis, By Treatment, 2020-2027
10.2.4 Spain
10.2.4.1 Market size analysis, By Product, 2020-2027
10.2.4.2 Market size analysis, By Application, 2020-2027
10.2.4.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.4.4 Market size analysis, By Testing Type, 2020-2027
10.2.4.5 Market size analysis, By Treatment, 2020-2027
10.2.5 Italy
10.2.5.1 Market size analysis, By Product, 2020-2027
10.2.5.2 Market size analysis, By Application, 2020-2027
10.2.5.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.5.4 Market size analysis, By Testing Type, 2020-2027
10.2.5.5 Market size analysis, By Treatment, 2020-2027
10.2.6 Rest of Europe
10.2.6.1 Market size analysis, By Product, 2020-2027
10.2.6.2 Market size analysis, By Application, 2020-2027
10.2.6.3 Market size analysis, By Therapeutic Area, 2020-2027
10.2.6.4 Market size analysis, By Testing Type, 2020-2027
10.2.6.5 Market size analysis, By Treatment, 2020-2027
10.2.7 Research Dive Exclusive Insights
10.2.7.1 Market attractiveness
10.2.7.2 Competition heatmap
10.3 Asia-Pacific
10.3.1 China
10.3.1.1 Market size analysis, By Product, 2020-2027
10.3.1.2 Market size analysis, By Application, 2020-2027
10.3.1.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.1.4 Market size analysis, By Testing Type, 2020-2027
10.3.1.5 Market size analysis, By Treatment, 2020-2027
10.3.2 Japan
10.3.2.1 Market size analysis, By Product, 2020-2027
10.3.2.2 Market size analysis, By Application, 2020-2027
10.3.2.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.2.4 Market size analysis, By Testing Type, 2020-2027
10.3.2.5 Market size analysis, By Treatment, 2020-2027
10.3.3 India
10.3.3.1 Market size analysis, By Product, 2020-2027
10.3.3.2 Market size analysis, By Application, 2020-2027
10.3.3.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.3.4 Market size analysis, By Testing Type, 2020-2027
10.3.3.5 Market size analysis, By Treatment, 2020-2027
10.3.4 Australia
10.3.4.1 Market size analysis, By Product, 2020-2027
10.3.4.2 Market size analysis, By Application, 2020-2027
10.3.4.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.4.4 Market size analysis, By Testing Type, 2020-2027
10.3.4.5 Market size analysis, By Treatment, 2020-2027
10.3.5 South Korea
10.3.5.1 Market size analysis, By Product, 2020-2027
10.3.5.2 Market size analysis, By Application, 2020-2027
10.3.5.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.5.4 Market size analysis, By Testing Type, 2020-2027
10.3.5.5 Market size analysis, By Treatment, 2020-2027
10.3.6 Rest of Asia-Pacific
10.3.6.1 Market size analysis, By Product, 2020-2027
10.3.6.2 Market size analysis, By Application, 2020-2027
10.3.6.3 Market size analysis, By Therapeutic Area, 2020-2027
10.3.6.4 Market size analysis, By Testing Type, 2020-2027
10.3.6.5 Market size analysis, By Treatment, 2020-2027
10.3.7 Research Dive Exclusive Insights
10.3.7.1 Market attractiveness
10.3.7.2 Competition heatmap
10.4 LAMEA
10.4.1 Brazil
10.4.1.1 Market size analysis, By Product, 2020-2027
10.4.1.2 Market size analysis, By Application, 2020-2027
10.4.1.3 Market size analysis, By Therapeutic Area, 2020-2027
10.4.1.4 Market size analysis, By Testing Type, 2020-2027
10.4.1.5 Market size analysis, By Treatment, 2020-2027
10.4.2 Saudi Arabia
10.4.2.1 Market size analysis, By Product, 2020-2027
10.4.2.2 Market size analysis, By Application, 2020-2027
10.4.2.3 Market size analysis, By Therapeutic Area, 2020-2027
10.4.2.4 Market size analysis, By Testing Type, 2020-2027
10.4.2.5 Market size analysis, By Treatment, 2020-2027
10.4.3 UAE
10.4.3.1 Market size analysis, By Product, 2020-2027
10.4.3.2 Market size analysis, By Application, 2020-2027
10.4.3.3 Market size analysis, By Therapeutic Area, 2020-2027
10.4.3.4 Market size analysis, By Testing Type, 2020-2027
10.4.3.5 Market size analysis, By Treatment, 2020-2027
10.4.4 South Africa
10.4.4.1 Market size analysis, By Product, 2020-2027
10.4.4.2 Market size analysis, By Application, 2020-2027
10.4.4.3 Market size analysis, By Therapeutic Area, 2020-2027
10.4.4.4 Market size analysis, By Testing Type, 2020-2027
10.4.4.5 Market size analysis, By Treatment, 2020-2027
10.4.5 Rest of LAMEA
10.4.5.1 Market size analysis, By Product, 2020-2027
10.4.5.2 Market size analysis, By Application, 2020-2027
10.4.5.3 Market size analysis, By Therapeutic Area, 2020-2027
10.4.5.4 Market size analysis, By Testing Type, 2020-2027
10.4.5.5 Market size analysis, By Treatment, 2020-2027
10.4.6 Research Dive Exclusive Insights
10.4.6.1 Market attractiveness
10.4.6.2 Competition heatmap
11. Competitive Landscape
11.1 Top winning strategies, 2020-2027
11.1.1 By strategy
11.1.2 By year
11.2 Strategic overview
11.3 Market share analysis, 2020-2027
12. Company Profiles
12.1 Sanofi
12.1.1 Overview
12.1.2 Business segments
12.1.3 Product portfolio
12.1.4 Financial performance
12.1.5 Recent developments
12.1.6 SWOT analysis
12.2 AstraZeneca
12.2.1 Overview
12.2.2 Business segments
12.2.3 Product portfolio
12.2.4 Financial performance
12.2.5 Recent developments
12.2.6 SWOT analysis
12.3 GlaxoSmithKline
12.3.1 Overview
12.3.2 Business segments
12.3.3 Product portfolio
12.3.4 Financial performance
12.3.5 Recent developments
12.3.6 SWOT analysis
12.4 Serum Institute of India
12.4.1 Overview
12.4.2 Business segments
12.4.3 Product portfolio
12.4.4 Financial performance
12.4.5 Recent developments
12.4.6 SWOT analysis
12.5 Abbott
12.5.1 Overview
12.5.2 Business segments
12.5.3 Product portfolio
12.5.4 Financial performance
12.5.5 Recent developments
12.5.6 SWOT analysis
12.6 Zydus Cadila
12.6.1 Overview
12.6.2 Business segments
12.6.3 Product portfolio
12.6.4 Financial performance
12.6.5 Recent developments
12.6.6 SWOT analysis
12.7 Bharat Biotech
12.7.1 Overview
12.7.2 Business segments
12.7.3 Product portfolio
12.7.4 Financial performance
12.7.5 Recent developments
12.7.6 SWOT analysis
12.8 Panacea Biotec
12.8.1 Overview
12.8.2 Business segments
12.8.3 Product portfolio
12.8.4 Financial performance
12.8.5 Recent developments
12.8.6 SWOT analysis
12.9 Mylan
12.9.1 Overview
12.9.2 Business segments
12.9.3 Product portfolio
12.9.4 Financial performance
12.9.5 Recent developments
12.9.6 SWOT analysis
12.10 Seqirus
12.10.1 Overview
12.10.2 Business segments
12.10.3 Product portfolio
12.10.4 Financial performance
12.10.5 Recent developments
12.10.6 SWOT analysis
12.11 Sinovac Biotech
12.11.1 Overview
12.11.2 Business segments
12.11.3 Product portfolio
12.11.4 Financial performance
12.11.5 Recent developments
12.11.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
